AnalystsRyan DeschnerRyan Deschner's Stock Forecasts
AnalystsRyan Deschner
Sectors:
Industries:
Analyst Ranking
Top 25%
#1201 out of 4906 analysts
Average Return
+31.34%
Win Rate
67%8 out of 12
Risk vs Reward
Poor
Good
Ryan Deschner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Inozyme Pharma IncINZY | +269.44% | $1.08 | $3.99 | 2025-03-12 - 2025-06-13 | Buy |
Trevi Therapeutics IncTRVI | +92.72% | $3.16 | $6.09 | 2024-08-30 - 2025-06-13 | Buy |
Liquidia CorpLQDA | +44.02% | $9.79 | $14.10 | 2024-08-19 - 2025-06-13 | Strong Buy |
Ars Pharmaceuticals IncSPRY | +37.53% | $11.19 | $15.39 | 2024-07-25 - 2025-06-13 | Buy |
Ars Pharmaceuticals IncSPRY | +35.48% | $11.36 | $15.39 | 2025-01-14 - 2025-06-13 | Strong Buy |
Ryan Deschner Analyst Color
Get additional color on Ryan Deschner's coverage of popular stocks
Ryan Deschner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inozyme Pharma IncINZY | 2 | Hold | $4.00 | +0.25% | Downgrades | a month ago |
Apellis Pharmaceuticals IncAPLS | 1 | Buy | $52.00 | +176.16% | Downgrades | a month ago |
Liquidia CorpLQDA | 3 | Strong Buy | $29.00 | +105.67% | Maintains | a month ago |
Trevi Therapeutics IncTRVI | 2 | Strong Buy | $29.00 | +376.19% | Upgrades | 3 months ago |
Ardelyx IncARDX | 1 | Strong Buy | $13.00 | +261.11% | Reiterates | 4 months ago |
Ars Pharmaceuticals IncSPRY | 3 | Strong Buy | $28.00 | +81.94% | Maintains | 5 months ago |
Omega Therapeutics IncOMGAQ | 1 | Buy | $12.00 | +8,291.61% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.